Pay in 4 interest-free payments of $5.07 Learn more
.png)
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
PatentUS20230278991A1
Standard titration schedules are already designed to minimize side effects by starting at a low dose and increasing gradually
Unlike our study, some cases of hypoglycemia and gallbladder disease were reported (20)
[16] [19] Subsequent analysis of SUSTAIN-6 data revealed that the increased risk was concentrated among patients who entered the trial with pre-existing diabetic retinopathy and experienced rapid improvements in glycemic control
US$ 25.92
US$ 22.76
US$ 24.95
US$ 28.65
US$ 25.91
US$ 26.28
